Find a Provider

K. Rajender Reddy, MD Physician

Director, Hepatology
Professor of Medicine in Surgery
Ruimy Family President's Distinguished Professor

Dr. Reddy is a Penn Medicine employed physician.

About Dr. K Reddy

Recognized by America's Top Doctors, 2007, 2008, 2010, 2012-14

Recognized by Best Doctors in America 2005-2006, 2007-2008, 2009-2010, 2011-2012

Recognized in Philadelphia Magazine's 2010 Top Docs issue

Clinical Specialties


  • Medicine
    • Gastroenterology

Programs & Services:

  • Cancer
    • Anal Cancer
    • Colon Cancer
    • Esophageal Cancer
    • Gastrointestinal (GI) Cancer Risk Evaluation Program
    • Gastrointestinal Cancer Evaluation Center (GICEC)
    • Gastrointestinal Carcinoid Tumor
    • Liver Cancer
    • Pancreatic Cancer
    • Rectal Cancer
    • Small Intestine Cancer
    • Stomach (Gastric) Cancer
  • Gastroenterology
    • Liver Disease
  • Transplant
    • Liver Transplant

Board Certification:

  • Gastroenterology, 1983
  • Internal Medicine, 1980
  • Transplant Hepatology, 2006

Conditions & Treatments:

  • Anal Cancer
  • Ascites
  • Bile Duct Cancer
  • Colon Cancer
  • Esophageal Cancer
  • esophageal varices
  • Gallbladder Cancer
  • Gastrointestinal Carcinoid Tumor
  • hepatic encephalopathy
  • hepatitis - autoimmune
  • hepatitis B - viral
  • hepatitis C - viral
  • Liver Cancer
  • Liver Cirrhosis
  • liver transplant evaluation
  • Neuroendocrine Tumors
  • Pancreatic Cancer
  • portal hypertension
  • primary biliary cirrhosis
  • primary sclerosing cholangitis
  • Rectal Cancer
  • Small Intestine Cancer
  • Stomach (Gastric) Cancer
  • transjugular intrahepatic portosystemic shunt (TIPS)

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Osmania Medical College
Residency: Misericordia Hospital
Fellowship: University of Tennessee Medical Center
Fellowship: University of Miami Hospital and Clinic


American Association for the Study of Liver Diseases (AASLD), National American Association for the Study of Liver Diseases, National American Association for the Study of Liver Diseases, National American College of Gastroenterology, Fellow, National American College of Gastroenterology, National American College of Physicians, Fellow, National American Gastroenterological Association, National American Society of Gastrointestinal Endoscopy, National NIDDK/NIH; ALFSG, National NIDDK/NIH; DILI Network and ALFSG, National NIDDK/NIH; DILI Network, National


Dr. Reddy is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Medicine Radnor: Has privileges to perform procedures.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.


Selected Publications:

Yoshida EM, Sulkowski MS, Gane EJ, Herring RW Jr, Ratziu V, Ding X, Wang J, Chuang SM, Ma J, McNally J, Stamm LM, Brainard DM, Symonds WT, McHutchison JG, Beavers KL, Jacobson IM, Reddy KR, Lawitz E: Concordance of Sustained Virologic Response 4, 12, 24 Weeks Post-Treatment With Sofosbuvir-Containing Regimens for Hepatitis C Virus Hepatology : 2014.

Gordon SC, Muir AJ, Lim JK, Pearlman B, Argo CK, Ramani A, Maliakkal B, Alam I, Stewart TG, Vainorius M, Peter J, Nelson DR, Fried MW, Reddy KR: Safety Profile of Boceprevir and Telaprevir in Chronic Hepatitis C: Real World Experience From HCV-Target J Hepatol HCV-Target Study Group : 2014.

O'Leary, Reddy KR, Wong F, Kamath PS, Patton HM, Biggins SW, Fallon MB, Garcia-Tsao G, Subramanian RM, Malik R, Thacker LR, Bajaj JS: North American Consortium for the Study of End-Stage Liver Disease Long-term Use of Antibiotics and Proton Pump Inhibitors Predict Development of Infections in Patients with Cirrhosis Clin Gastroenterol Hepatol : 2014.

Flamm SL1, Muir AJ, Fried MW, Reddy KR, Nelson DR, Bzowej NH, Sullivan JC, Bengtsson L, DeMasi R, Wright CI, Kieffer TL, George S, Adda N, Dusheiko GM.: Sustained Virologic Response Rates With Telaprevir-Based Therapy in Treatment-Naive Patients Evaluated by Race or Ethnicity. J Clin Gastroenterol : 2014.

Reddy KR1, Wirjosemito A, Pavri TM, Sinese L.: HCV therapy with daclatasvir, PEG-IFN, and RBV after boceprevir-based therapy failure post-liver transplantation in hyper-IgM syndrome. Transplantation. : 2014.

Fontana RJ, Hayashi PH, Gu J, Reddy KR, Barnhart H, Watkins PB, Serrano J, Lee WM, Chalasani N, Stolz A, Davern T, Talwakar JA; on behalf of the DILIN network.: Idiosyncratic Drug Induced Liver Injury is associated with Substantial Morbidity and Mortality within 6 months From Onset Gastroenterology. : pii: S0016-5085(14)00429-6,2014.

Lo Re V 3rd, Kallan MJ, Tate JP, Localio AR, Lim JK, Goetz MB, Klein MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Gibert CL, Brown ST, Park L, Dubrow R, Reddy KR, Kostman JR, Strom BL, Justice AC.: Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study. Ann Intern Med. : 2014.

Clayton EF, Malik S, Bonnel A, Mu Y, Olthoff K, Shaked A, Abt PL, Peterman H, Reddy KR, Ottmann S, Furth EE, Levine MH.: Liver Transplantation and cirrhotomimetic hepatocellular carcinoma: Classification and outcomes. Liver Transpl. : 2014.

Hayashi PH, Barnhart HX, Fontana RJ, Chalasani N, Davern TJ, Talwalkar JA, Reddy KR, Stolz AA, Hoofnagle JH, Rockey DC.: Reliability of Causality Assessment for Drug, Herbal and Dietary Supplement Hepatoxicity in the Drug-Induced Liver Injury Network (DILIN) Liver Int. : 2014.

Terrault N, Reddy KR, Poordad F, Curry M, Schiano T, Johl J, Shaikh O, Dove L, Shetty K, Millis M, Schiff E, Regenstein F, Barnes D, Barin B, Peters M, Roland M, Stock P; for the HIVTR Investigators.: Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV-HIV Coinfected Liver Transplant Recipients Am J Transplant. : 2014.

View all publications

Academic Contact Info

Division of Gastroenterology, 2 Dulles
3400 Spruce Street
Hospital of the University of Pennsylvania

Philadelphia, PA 19104
Phone: (215) 662-4276
Fax: (215) 349-5915
Patient appointments: 800-789-PENN (7366)

Related Links